Available data on the efficacy of surgical treatment is inconclusive (Lee 2014), but is unlikely to be beneficial in those with motility problems that extend to the small intestine and stomach (Rao 2014)
Fermentum ME-3, a patented lactic acid bacteria strain, is used under an exclusive license agreement with the University of Tartu, Estonia
Mohamed, Caroline Ankoma-Sey, Sherry Fares, Mazen Elsheikh, Megha B
Its anti-atherogenic actions include nitric oxide production, inhibition of cell proliferation in vascular smooth muscle cell proliferation, and suppression of inflammatory responses in monocytes, macrophages, and adipocytes
Guidance for industry: diabetes mellitus evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes